First human tests begin for new prostate drugs

NCT ID NCT07444385

Summary

This early-stage study aims to check the safety and measure how two new drugs for enlarged prostate (BPH) move through the body in healthy men after they eat a meal. It involves 44 healthy adult male volunteers who will receive single doses of the drugs. The main goal is to see how the body processes the drugs and to identify any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERPLASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • H PLUS YANGJI HOSPITAL, Seoul

    RECRUITING

    Seoul, South Korea

Conditions

Explore the condition pages connected to this study.